Clal Biotechnology Industries Ltd. (TASE: CBI) | Jewish Business News

Home Tags Clal Biotechnology Industries Ltd. (TASE: CBI)

Medivation takes up $335 million Curetech licensing option

Koby Yeshayahou - December 21, 2014 0

Investor files class action on Andromeda biotech

Gali Weinreb - September 10, 2014 0

Len Blavatnik donates $20 million to Tel Aviv University

Gali Weinreb - September 8, 2014 0

Novartis abandons plans to buy Israeli stem cell treatment company Gamida...

Gali Weinreb - May 1, 2014 0

Israeli Mediwound Begins Trading On Nasdaq

Jewish Business News Correspondent - March 20, 2014 0

Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-Cell

Ilan Shavit - March 18, 2014 0

Clal Biotech Selling Diabetes Treatment Co Andromeda

Koby Yeshayahou - February 26, 2014 0

Teva Sells Andromeda Diabetes Treatment Stake For $72 Million

Gali Weinreb - February 20, 2014 0

More Israeli Life Sciences Companies Going To Nasdaq

Gali Weinreb - February 3, 2014 0

Len Blavatnik to delist Clal Industries from the Tel Aviv Stock...

Albert Hecht - October 3, 2013 0

12 Page 1 of 2